Stay updated on Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0 while the study record remained unavailable.
    Difference
    0.2%
    Check dated 2026-11-03T06:20:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-27T06:45:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site's footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-20T08:20:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T08:24:56.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record. Access to the study details is blocked, indicating a restriction or outage.
    Difference
    20%
    Check dated 2026-09-22T06:56:40.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.5 to v3.6.6, indicating a new release of the page. No specific content changes are described in the provided data.
    Difference
    0.1%
    Check dated 2026-08-31T23:50:56.000Z thumbnail image

Stay in the know with updates to Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.